Prostate cancer: The genomics of localized disease (Nature Clinical Practice Urology)

Most men with prostate cancer are diagnosed before the disease has become metastatic, but currently available prognostic factors do not enable optimum risk stratification in this patient group. Now, new genomic sequencing data from samples of localized but nonindolent prostate tumours indicate several molecular aberrations